[1]
Zaniolo, O. et al. 2008. Budget impact of vildagliptin. Farmeconomia. Health economics and therapeutic pathways. 9, 3 (Sep. 2008), 137–146. DOI:https://doi.org/10.7175/fe.v9i3.227.